Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 147.80
+2.70 (1.86%)
At close: Aug 13, 2026
DSE:BXPHARMA Market Cap
DSE:BXPHARMA has a market cap or net worth of 65.94 billion as of August 14, 2026. Its market cap has increased by 33.76% in one year.
Market Cap
65.94B
Enterprise Value
67.36B
Revenue
53.93B
Ranking
n/a
PE Ratio
7.62
Stock Price
147.80
ChartMarket Cap Chart
Since January 3, 2000, DSE:BXPHARMA's market cap has increased from 1.91B to 65.94B, an increase of 3,350.47%. That is a compound annual growth rate of 14.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 65.94B | 44.76% |
| Dec 30, 2025 | 45.55B | 25.12% |
| Dec 30, 2024 | 36.40B | -44.19% |
| Dec 28, 2023 | 65.22B | - |
| Dec 29, 2022 | 65.22B | -24.13% |
| Dec 30, 2021 | 85.97B | 1.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 194.31B |
| Renata | 54.10B |
| Unilever Consumer Care | 39.32B |
| Beacon Pharmaceuticals | 24.76B |
| The ACME Laboratories | 17.61B |
| Asiatic Laboratories | 14.34B |
| The IBN SINA Pharmaceutical Industry | 10.07B |
| Navana Pharmaceuticals | 7.45B |